Constitutively Active NFκB Is Required for the Survival of S-type Neuroblastoma

This publication has 43 references indexed in Scilit:

• NF-κB Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma Cells
  Journal of Biological Chemistry, 2001
• Surface Antigen Expression and Complement Susceptibility of Differentiated Neuroblastoma Clones
  The American Journal of Pathology, 2000
• Aberrant rel/nfkb genes and activity in human cancer
  Oncogene, 1999
• The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFκB
  FEBS Letters, 1998
• Signal transduction through NF-κB
  Immunology Today, 1998
• Bcl-2 Suppresses Apoptosis Resulting from Disruption of the NF-κB Survival Pathway☆
  Experimental Cell Research, 1997
• Role of multiple cellular proteases in the execution of programmed cell death
  FEBS Letters, 1995
• Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: Correlation with expression of growth factors and growth factor receptors
  Journal of Neuroscience Research, 1995
• Adjuvant Chemotherapy for Murine Neuroblastoma with Special Reference to Cell Kinetics of Residual Tumor after Primary Tumor Removal
  Oncology, 1988
• Effect of antineoplastic drugs on human leukocyte-mediated cytotoxicity against herpes simplex virus infected cells
  Cancer, 1980